APA

Ojeda J., Arredondo J. L., Salcedo P., Paredes-Paredes M., Dupuy M., Petit C., Chabanon A. L., Rivas E., Gurunathan S., De Bruijn I. & Pepin S. (20210621). Immunogenicity and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase III trial. : Human vaccines & immunotherapeutics.

Chicago

Ojeda Joyce, Arredondo José Luis, Salcedo Perla, Paredes-Paredes Mercedes, Dupuy Martin, Petit Celine, Chabanon Anne Laure, Rivas Enrique, Gurunathan Sanjay, De Bruijn Iris and Pepin Stephanie. 20210621. Immunogenicity and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase III trial. : Human vaccines & immunotherapeutics.

Harvard

Ojeda J., Arredondo J. L., Salcedo P., Paredes-Paredes M., Dupuy M., Petit C., Chabanon A. L., Rivas E., Gurunathan S., De Bruijn I. and Pepin S. (20210621). Immunogenicity and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase III trial. : Human vaccines & immunotherapeutics.

MLA

Ojeda Joyce, Arredondo José Luis, Salcedo Perla, Paredes-Paredes Mercedes, Dupuy Martin, Petit Celine, Chabanon Anne Laure, Rivas Enrique, Gurunathan Sanjay, De Bruijn Iris and Pepin Stephanie. Immunogenicity and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase III trial. : Human vaccines & immunotherapeutics. 20210621.